Benitec Biopharma Inc.

NASDAQ (USD): Benitec Biopharma Inc. (BNTC)

Last Price

11.41

Today's Change

-0.76 (6.24%)

Day's Change

11.41 - 12.40

Trading Volume

401,448

Overview

Market Cap

264 Million

Shares Outstanding

23 Million

Avg Volume

43,901

Avg Price (50 Days)

10.78

Avg Price (200 Days)

8.63

PE Ratio

-3.88

EPS

-2.94

Earnings Announcement

11-Feb-2025

Previous Close

12.17

Open

12.02

Day's Range

11.41 - 12.4

Year Range

2.69 - 13.29

Trading Volume

106,205

Price Change Highlight

1 Day Change

-6.24%

5 Day Change

-4.92%

1 Month Change

8.77%

3 Month Change

22.69%

6 Month Change

65.84%

Ytd Change

248.93%

1 Year Change

242.64%

3 Year Change

-75.23%

5 Year Change

-89.86%

10 Year Change

-99.69%

Max Change

-99.81%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment